Synthesis and antileishmanial activity of novel pyridinium-hydrazone derivatives

References

• Otero ACS, Da-Silvia VO, Luz, KG, Palatnik M, Pirmez C, Fernandes O, De-Sousa CBP. Short report: Occurence of Leishmania donovani DNA in donated blood from seroreactive Brazilian blood donors. Am J Trop Med Hyg 2000;62:128–131.
   PubMed Web of Science ®Google Scholar
• Pearson RD, Sousa AQ. (1995). Leishmania species: Visceral (kala-azar), cutaneous and mucosal leishmaniasis. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. 4th ed. New York: Churchill Livingstone, 2428–2442.
   Google Scholar
• Murray HW. Treatment of visceral leishmaniasis in 2004. Am J Trop Med Hyg 2004;71:787–794.
   PubMed Web of Science ®Google Scholar
• Croft SL. Recent developments in the chemotherapy of leishmaniasis. Trends Pharmacol Sci 1988;9:376–381.
   PubMed Web of Science ®Google Scholar
• Berman JD. Chemotherapy for leishmaniasis: Biochemical mechanisms, clinical efficacy, and future strategies. Rev Infect Dis 1988;10:560–586.
   PubMedGoogle Scholar
• Khan F, Choudhary M, Rasheed M, Ullah Z, Hayat S, Kaukab F et al. Synthesis and in vitro leishmanicidal activity of some hydrazides and their analogues. Bioorg Med Chem 2003;11:1381–1387.
   PubMed Web of Science ®Google Scholar
• Zhai L, Chen M, Blom J, Theander TG, Christensen SB, Kharazmi A. The antileishmanial activity of novel oxygenated chalcones and their mechanism of action. J Antimicrob Chemother 1999;43:793–803.
   PubMed Web of Science ®Google Scholar
• de Mello H, Echevarria A, Bernardino AM, Canto-Cavalheiro M, Leon LL. Antileishmanial pyrazolopyridine derivatives: Synthesis and structure-activity relationship analysis. J Med Chem 2004;47:5427–5432.
   PubMed Web of Science ®Google Scholar
• Chakrabarti G, Basu A, Manna PP, Mahato SB, Mandal NB, Bandyopadhyay S. Indolylquinoline derivatives are cytotoxic to Leishmania donovani promastigotes and amastigotes in vitro and are effective in treating murine visceral leishmaniasis. J Antimicrob Chemother 1999;43:359–366.
   PubMed Web of Science ®Google Scholar
• Agarwal KC, Sharma V, Shakya N, Gupta S. Design and synthesis of novel substituted quinazoline derivatives as antileishmanial agents. Bioorg Med Chem Lett 2009;19:5474–5477.
   PubMed Web of Science ®Google Scholar
• Delmas F, Avellaneda A, Di Giorgio C, Robin M, De Clercq E, Timon-David P et al. Synthesis and antileishmanial activity of (1,3-benzothiazol-2-yl) amino-9-(10H)-acridinone derivatives. Eur J Med Chem 2004;39:685–690.
   PubMed Web of Science ®Google Scholar
• Chandra N, Ramesh, Ashutosh, Goyal N, Suryawanshi SN, Gupta S. Antileishmanial agents part-IV: Synthesis and antileishmanial activity of novel terpenyl pyrimidines. Eur J Med Chem 2005;40:552–556.
   PubMed Web of Science ®Google Scholar
• Rathelot P, Azas N, El-Kashef H, Delmas F, Di Giorgio C, Timon-David P et al. 1,3-Diphenylpyrazoles: Synthesis and antiparasitic activities of azomethine derivatives. Eur J Med Chem 2002;37:671–679.
   PubMed Web of Science ®Google Scholar
• Delmas F, Di Giorgio C, Robin M, Azas N, Gasquet M, Detang C et al. In vitro activities of position 2 substitution-bearing 6-nitro- and 6-amino-benzothiazoles and their corresponding anthranilic acid derivatives against Leishmania infantum and Trichomonas vaginalis. Antimicrob Agents Chemother 2002;46:2588–2594.
   PubMed Web of Science ®Google Scholar
• Bhandari K, Srinivas N, Marrapu VK, Verma A, Srivastava S, Gupta S. Synthesis of substituted aryloxy alkyl and aryloxy aryl alkyl imidazoles as antileishmanial agents. Bioorg Med Chem Lett 2010;20:291–293.
   PubMed Web of Science ®Google Scholar
• Poorrajab F, Ardestani SK, Emami S, Behrouzi-Fardmoghadam M, Shafiee A, Foroumadi A. Nitroimidazolyl-1,3,4-thiadiazole-based anti-leishmanial agents: Synthesis and in vitro biological evaluation. Eur J Med Chem 2009;44:1758–1762.
   PubMed Web of Science ®Google Scholar
• Croft SL, Snowdon D, Yardley V. The activities of four anticancer alkyllysophospholipids against Leishmania donovani, Trypanosoma cruzi and Trypanosoma brucei. J Antimicrob Chemother 1996;38:1041–1047.
   PubMed Web of Science ®Google Scholar
• Coghi P, Vaiana N, Pezzano MG, Rizzi L, Kaiser M, Brun R et al. Parallel synthesis and antileishmanial activity of ether-linked phospholipids. Bioorg Med Chem Lett 2008;18:4658–4660.
   PubMed Web of Science ®Google Scholar
• Aponte JC, Castillo D, Estevez Y, Gonzalez G, Arevalo J, Hammond GB et al. In vitro and in vivo anti-Leishmania activity of polysubstituted synthetic chalcones. Bioorg Med Chem Lett 2010;20:100–103.
   PubMed Web of Science ®Google Scholar
• Mayence A, Vanden Eynde JJ, LeCour L Jr, Walker LA, Tekwani BL, Huang TL. Piperazine-linked bisbenzamidines: A novel class of antileishmanial agents. Eur J Med Chem 2004;39:547–553.
   PubMed Web of Science ®Google Scholar
• Mäntylä A, Rautio J, Nevalainen T, Vepsälainen J, Juvonen R, Kendrick H et al. Synthesis and antileishmanial activity of novel buparvaquone oxime derivatives. Bioorg Med Chem 2004;12:3497–3502.
   PubMed Web of Science ®Google Scholar
• Paloque L, Bouhlel A, Curti C, Dumètre A, Verhaeghe P, Azas N et al. Synthesis and evaluation of monoamidoxime derivatives: Toward new antileishmanial compounds. Eur J Med Chem 2011;46:2984–2991.
   PubMed Web of Science ®Google Scholar
• Visbal G, Marchán E, Maldonado A, Simoni Z, Navarro M. Synthesis and characterization of platinum-sterol hydrazone complexes with biological activity against Leishmania (L.) mexicana. J Inorg Biochem 2008;102:547–554.
   PubMed Web of Science ®Google Scholar
• Rando DG, Avery MA, Tekwani BL, Khan SI, Ferreira EI. Antileishmanial activity screening of 5-nitro-2-heterocyclic benzylidene hydrazides. Bioorg Med Chem 2008;16:6724–6731.
   PubMed Web of Science ®Google Scholar
• Saudi MNS, El-Semary MMA, Elbayaa RY, Jaeda MI, Eissa MM, Amer EI et al. Synthesis and biological evaluation of a novel classas antileishmanial agent. Med Chem Res 2012;21:257–267.
   Web of Science ®Google Scholar
• da Silva EF, Canto-Cavalheiro MM, Braz VR, Cysne-Finkelstein L, Leon LL, Echevarria A. Synthesis, and biological evaluation of new 1,3,4-thiadiazolium-2-phenylamine derivatives against Leishmania amazonensis promastigotes and amastigotes. Eur J Med Chem 2002;37:979–984.
   PubMed Web of Science ®Google Scholar
• Rodrigues RF, da Silva EF, Echevarria A, Fajardo-Bonin R, Amaral VF, Leon LL et al. A comparative study of mesoionic compounds in Leishmania sp. and toxicity evaluation. Eur J Med Chem 2007;42:1039–1043.
   PubMed Web of Science ®Google Scholar
• Ponte-Sucre A, Gulder T, Wegehaupt A, Albert C, Rikanovic C, Schaeflein L et al. Structure-activity relationship and studies on the molecular mechanism of leishmanicidal N,C-coupled arylisoquinolinium salts. J Med Chem 2009;52:626–636.
   PubMed Web of Science ®Google Scholar
• Sundberg RJ, Dahlhausen DJ, Manikumar G, Mavunkel B, Biswas A, Srinivasan V et al. Cationic antiprotozoal drugs. Trypanocidal activity of 2-(4′-formylphenyl)imidazo[1,2-a]pyridinium guanylhydrazones and related derivatives of quaternary heteroaromatic compounds. J Med Chem 1990;33:298–307.
   PubMed Web of Science ®Google Scholar
• Khan MO, Austin SE, Chan C, Yin H, Marks D, Vaghjiani SN et al. Use of an additional hydrophobic binding site, the Z site, in the rational drug design of a new class of stronger trypanothione reductase inhibitor, quaternary alkylammonium phenothiazines. J Med Chem 2000;43:3148–3156.
   PubMed Web of Science ®Google Scholar
• Zhu XY, Mardenborough LG, Li S, Khan A, Zhang W, Fan P et al. Synthesis and evaluation of isosteres of N-methyl indolo[3,2-b]-quinoline (cryptolepine) as new antiinfective agents. Bioorg Med Chem 2007;15:686–695.
   PubMed Web of Science ®Google Scholar
• Tischer M, Sologub L, Pradel G, Holzgrabe U. The bisnaphthalimides as new active lead compounds against Plasmodium falciparum. Bioorg Med Chem 2010;18:2998–3003.
   PubMed Web of Science ®Google Scholar
• Zanetti S, Fiori PL, Pinna A, Usai S, Carta F, Fadda G. Susceptibility of Acanthamoeba castellanii to contact lens disinfecting solutions. Antimicrob Agents Chemother 1995;39:1596–1598.
   PubMed Web of Science ®Google Scholar
• Bharate SB, Thompson CM. Antimicrobial, antimalarial, and antileishmanial activities of mono- and bis-quaternary pyridinium compounds. Chem Biol Drug Des 2010;76:546–551.
   PubMed Web of Science ®Google Scholar
• Alptüzün V, Parlar S, Tasli H, Erciyas E. Synthesis and antimicrobial activity of some pyridinium salts. Molecules 2009;14:5203–5215.
   PubMed Web of Science ®Google Scholar
• Alptüzün V, Prinz M, Hörr V, Scheiber J, Radacki K, Fallarero A et al. Interaction of (benzylidene-hydrazono)-1,4-dihydropyridines with beta-amyloid, acetylcholine, and butyrylcholine esterases. Bioorg Med Chem 2010;18:2049–2059.
   PubMed Web of Science ®Google Scholar
• Aydın A, Akkurt M, Alptuzun V, Buyukgungor O, Holzgrabe U, Radacki K. 4-[(2E)-2-(4-Chlorobenzylidene)hydrazinylidene]-1-methyl-1,4-dihydropyridine monohydrate. Acta Cryst Sec E 2010;66:1324–1325.
   Google Scholar
• Giger R, Meier HP, Küpfer U. [Length of gestation of Freiberger mares with mule and horse foals]. Schweiz Arch Tierheilkd 1997;139:303–307.
   PubMed Web of Science ®Google Scholar
• Ostan I, Saglam H, Limoncu ME, Ertabaklar H, Toz SO, Ozbel Y et al. In vitro and in vivo activities of Haplophyllum myrtifolium against Leishmania tropica. New Microbiol 2007;30:439–445.
   PubMed Web of Science ®Google Scholar
• Chan C, Yin H, Garforth J, McKie JH, Jaouhari R, Speers P et al. Phenothiazine inhibitors of trypanothione reductase as potential antitrypanosomal and antileishmanial drugs. J Med Chem 1998;41:148–156.
   PubMed Web of Science ®Google Scholar
• Gao YG, Sriram M, Denny WA, Wang AH. Minor groove binding of SN6999 to an alkylated DNA: Molecular structure of d(CGC[e6G]AATTCGCG)-SN6999 complex. Biochemistry 1993;32:9639–9648.
   PubMed Web of Science ®Google Scholar
• Kourai H, Yabuhara T, Shirai A, Maeda T, Nagamune H. Syntheses and antimicrobial activities of a series of new bis-quaternary ammonium compounds. Eur J Med Chem 2006;41:437–444.
   PubMed Web of Science ®Google Scholar
• Madaan P, Tyagi VK. Quaternary pyridinium salts: A review. J Oleo Sci 2008;57:197–215.
   PubMed Web of Science ®Google Scholar
• Fairlamb AH, Blackburn P, Ulrich P, Chait BT, Cerami A. Trypanothione: A novel bis(glutathionyl)spermidine cofactor for glutathione reductase in trypanosomatids. Science 1985;227:1485–1487.
   PubMed Web of Science ®Google Scholar
• Prókai-Tátrai K, Pop E, Anderson W, Lin JL, Brewster ME, Bodor N. Redox derivatives of tranylcypromine: Syntheses, properties, and monoamine oxidase inhibitor activity of some chemical delivery systems. J Pharm Sci 1991;80:255–261.
   PubMed Web of Science ®Google Scholar
• Bodor N, AbdelAlim AM. Improved delivery through biological membranes XIX: Novel redox carriers for brain-specific chemical delivery systems. J Pharm Sci 1985;74:241–245.
   PubMed Web of Science ®Google Scholar
• Bodor N, Farag HH. Improved delivery through biological membranes. 13. Brain-specific delivery of dopamine with a dihydropyridine in equilibrium with pyridinium salt type redox delivery system. J Med Chem 1983;26:528–534.
   PubMed Web of Science ®Google Scholar
• Finney DG. (1971). Probit analysis. 3rd ed. London: Cambridge University Press.
   Google Scholar